Ipsen reports strong sales growth in first nine months of 2025, upgrades full-year guidance, and announces acquisition of ImCheck Therapeutics. Financial results and pipeline updates detailed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback